ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Human aldose reductase unfolds through an intermediate.

[version 1; peer review: 3 approved with reservations]
PUBLISHED 26 Apr 2019
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background: Human aldose reductase (hAR) converts glucose to sorbitol under hyperglycemic conditions. Aldose reductase is first and rate limiting enzyme of polyol pathway. Under hyperglycemia, increased flux of glucose through this pathway has been implicated in development of secondary complication in diabetes. Due to this clinical implication, aldose reductase attracted considerable attention from drug discovery perspective. In spite of extensive characterization of the biochemical and structural context, little is known about the unfolding behavior of aldose reductase. This study reports equilibrium unfolding studies of human aldose reductase.
Methods: We carried out thermal and chemical induced equilibrium unfolding studies of human aldose reductase monitored by circular dichroism and tryptophan and ANS fluorescence spectroscopy. 
Results: Thermal unfolding studies present a classical picture of two state unfolding from native to unfolded state. The data was used to derive thermodynamic parameters and study thermostability of aldose reductase. Urea and GuHCl induced equilibrium unfolding studies led us to discover an intermediate state, which gets populated at 3.5-4.0 M and 0.7-2 M of urea and GuHCl, respectively. Thermodynamic parameters from chemical induced unfolding are in agreement with those obtained from thermal unfolding.
Conclusion: This study revealed that aldose reductase unfolds from native to unfolded state via an intermediate. Assessment of thermodynamic stability of native, intermediate and unfolded state shows that three states are separated by significant energy barriers that ensure cooperativity of unfolding. As hAR functions in cells which are under osmotic and oxidative stress, these in vitro findings may have implications for its native conformation under physiological state.

Keywords

Aldose reductase, Protein unfolding, Folding intermediate, Cooperativity, Tryptophan fluorescence, ANS fluorescence, Thermal unfolding

Abbreviations

GuHCl, guanidine hydrochloride; TCEP, (tris(2-carboxyethyl)phosphine); ANS, 8-anilino-1-naphthalenesulfonic acid ammonium salt; IPTG, isopropyl β-D-1-thiogalactopyranoside; Trp, tryptophan.

Introduction

Human aldose reductase (hAR) (EC 1.1.1.21) is an NADPH-dependent oxidoreductase that belongs to super family of aldo-keto reductases1. Being the first and rate limiting enzyme of polyol pathway, hAR converts glucose to sorbitol2. Under hyperglycemic conditions, the polyol pathway is up-regulated and a significant proportion of glucose gets fluxed through this pathway, which leads to accumulation of sorbitol, consumption of NADPH and redox imbalance of NADPH/NADP+ ratio. All these factors have been linked with various tissue based pathologies associated with secondary complications of diabetes mellitus3. Due to its clinical importance, hAR has been widely studied from the perspective of development of potent inhibitors so as to prevent or delay the onset of secondary diabetic complications4.

Extensive information is available in the literature about the structure and function of hAR, particularly related to active site of hAR from ultra-high-resolution crystal structures with a number of potential inhibitors5, flexibility in the hAR binding site pocket6 and the thermodynamics of closing/opening of the specificity pocket within binding site pocket of hAR7. Nevertheless, there is little investigation related to the folding/unfolding mechanism of hAR. Understanding the capability of a polypeptide chain to spontaneously fold into a compact tertiary structure on biological relevant time scale is a long-standing challenge in protein science8.

Under physiological conditions, protein structure fluctuates among different native conformations separated by close free energy barriers9. Since hAR activity leads to sorbitol accumulation, leading to osmotic stress; it seems to function under stress conditions which might perturb its native conformation ensemble. Here we report on thermally and chemically induced unfolding studies of hAR. Thermal unfolding revealed simple two-state transition whereas chemical induced unfolding led us to discover an intermediate state during hAR unfolding.

Methods

Materials

All chemicals were reagent grade and purchased from Sigma-Aldrich.

Protein purification

The hAR cDNA cloned into expression vector pET-15b (Novagen) was a kind gift from Dr. Alberto Podjarny (Department of Integrated Structural Biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, France). The plasmid, coding for a hexahistidine-tagged protein, was expressed into E. coli strain BL21 (DE3) (Novagen). The cells with recombinant plasmid were grown with 100 μM ampicillin at 37°C to an OD600 nm value of 0.7 and protein expression was induced by adding 1 mM IPTG. Cells were grown for further 3 hours at 37°C. All further operations were carried out at 4°C unless otherwise stated. Cells were centrifuged, re-suspended and lysed by sonication. A Ni-NTA affinity column (GE Healthcare) was used for protein purification. The material used for stationary phase for the column was Ni-Sepharose and the flow rate of column was adjusted to 0.5 ml min-1. Imidazole and other salts were removed by repeated dialysis in 50 mM potassium phosphate, pH-7 buffer containing 50 mM NaCl. Protein concentration was estimated using the molar extinction coefficient and absorbance reading at 280 nm. The histidine tag from recombinant protein was removed by thrombin (4 units of thrombin per mg of recombinant protein at room temperature for 3 hours). Cleaved protein was passed through the Ni-NTA column, and purified protein without tag was collected as flow-through. Enzyme activity was checked as per standard assay10. Homogeneity and molecular weight of hAR with and without histidine tags was analyzed under denaturing conditions on 15% SDS-PAGE. Purified hAR was stored at -20°C for further studies.

Thermal unfolding

Thermal unfolding was carried out at a final concentration of 2.8 µM protein in 50 mM potassium phosphate buffer, pH 7.0 containing 50 mM NaCl and 0.1mM TCEP. Transition between 20–70 °C was followed using a far-UV circular dichroism (CD) signal at 222 nm by using 0.1 cm path length cuvette at sampling rate of 1.0 °C min-1 in a Jasco J-810 spectropolarimeter. Buffer blank was duly subtracted before reporting the change in ellipticity (millidegree) at 222 nm.

Chemical induced unfolding

Samples with 1.4 μM protein concentration were prepared in phosphate buffer (described earlier) containing different concentrations of GuHCl/urea. Samples were incubated for 12 hours to reach equilibrium at 25°C after which no change in signal occurred either in fluorescence or CD spectra. Trp fluorescence (excitation at 295 nm and emission recorded between 300 nm to 400 nm) and ANS fluorescence (excitation at 370 nm and emission recorded between 400 nm to 600 nm) measurements were performed using a Hitachi F-7000 fluorescence spectrophotometer for GuHCl samples and Jasco J-815 spectropolarimeter for urea samples. Far-UV CD measurements were performed using Jasco J-810 spectropolarimeter for GuHCl samples and Jasco J-815 spectropolarimeter for urea samples. Quartz cuvette of 1 cm and 0.5 cm path length were used for fluorescence and CD measurements respectively. All measurements were done at 25 °C. Spectra were reported as ellipticity (millidegree) after baseline correction.

Heat capacity change (ΔCp) calculations

ΔCp value for unfolding of hAR was calculated from change in accessible surface area (ΔASA) according to Equation 111

ΔCp=251+0.19×[ΔASA](Equation 1)

ProtSA web server was used to calculate change in accessible surface area from native to unfolded conformation of hAR12.

Data analysis

GraphPad Prism version 7.04 for Windows (GraphPad Software, La Jolla, California) was used for analysis of thermal and chemical induced unfolding data on the basis of two and three state model respectively as described in following sections.

Thermal unfolding

Data was fitted by least square analysis to Equation 213.

Y=(An+bN×T)+(Au+bU×T)×exp((ΔHgR)×(1Tg1T))1+exp((ΔHgR)×(1Tg1T))(Equation 2)

Where An and Au are native and unfolded state baseline intercepts respectively and bN and bU are native and unfolded baseline slopes respectively. ΔHm is enthalpy change at melting temperature (Tg). T is absolute temperature and R is the gas constant.

Calculation of ∆G values for transition region

Signal for native (YN = An + bN × T) and unfolded baseline (YU = Au + bU × T) for every point in transition region was calculated from Equation 2. If Y is signal for a particular point in transition region, then fraction of unfolded protein (Fu) at this point is given by Equation 3.

Fu=YnYYnYu(Equation 3)

The equilibrium constant (k) can be calculated from relative population of species using Equation 4.

k=Fu1Fu(Equation 4)

ΔG can be calculated as a function of temperature using Equation 5.

ΔG=RT ln k(Equation 5)

Thermal stability curve

The thermal stability curve of hAR was constructed on the basis of Equation 6–814.

ΔHT=ΔHg+ΔCp(TTg)(Equation 6)

ΔST=ΔHgTg+ΔCp×LN(TTg)(Equation 7)

ΔGs=ΔHg×(1TTg)+ΔCp×(TTg(T×LN(TTg)))(Equation 8)

Where ΔHT and ΔST are enthalpy and entropy change respectively at temperature T with reference to Tg. Th, Ts and Tg are the temperatures at which ∆H, ∆S, and ∆G are zero respectively. ∆Gs is the stabilization free energy of the native state relative to the unfolded state.

Chemical induced unfolding

Data was fitted by least square analysis to Equation 913.

Y=(An+bN×[D])+(Ai+bI×[D])×exp((ΔG(NI)R*Tm(NI)×[D]R*T))+(Au+bU×[D])×exp((ΔG(NI)R×Tm(NI)[D]R×T))×exp((ΔG(IU)R×Tm(IU)×[D]R×T))1+exp(ΔG(NI)R×Tm(NI)×[D]R×T)exp((ΔG(NI)R×Tm(NI)×[D]R×T))×exp((ΔG(IU)R×Tm(IU)×[D]R×T))(Equation 9)

Where An, Au, and Ai are the native, unfolded and intermediate baseline intercepts, respectively, and bN, bU and bI are the native, unfolded and intermediate baseline slopes, respectively. [D] is denaturant concentration in molar. m(N-I) and m(I-U) are denaturant gradient for native to intermediate and intermediate to unfolded state respectively. ∆G(N-I) and ∆G(I-U) are stabilization free energy of intermediate state relative to native and unfolded state respectively.

Results

Thermal unfolding monitored by far-UV CD

Change in ellipticity at 222 nm fitted well on the basis of a two-state model (Figure 1A). This analysis gave values for ΔHg and Tg which along with ΔCp value calculated from Equation 1 were used for non-linear regression of transition region (±5 kJ mol-1) to Equation 8 (Figure 1C). Values of ΔH and ΔS were calculated over extended range of temperature by using Equation 7 and Equation 8, respectively (Figure 1D). Thermal stability curve is extrapolation of transition region assuming constant ΔCp during unfolding transition (Figure 1E). The relationship between Ts, Th and ∆G (Ts – Th = ∆Gs/∆Cp) is presented in Figure 1F. Thermodynamic parameters obtained from analysis of thermal unfolding data are listed in Table 1. All raw data are available as Underlying data15.

292fcd34-6744-449e-ac7f-b211da161210_figure1.gif

Figure 1. Thermal unfolding studies of human aldose reductase (hAR) monitored by far-UV circular dichroism.

(A) Change in ellipticity at 222 nm plotted as a function of temperature. (B) Fraction of protein folded (green dots) and unfolded (red dots) plotted against temperature. (C) Portion of transition curve used in van't Hoff analysis. (D) Plots of ΔH and ΔS as function of temperature. (E) thermal stability curve of hAR. (F) Triangular relationship among Th, Ts and ∆Gs. Explanation for Tg, Tg’, Th and Ts is given in text. Dashed lines are extrapolations. Solid line represents fit to unfolding transition, filled symbols represent data points from unfolding experiments and red symbols represent outliers.

Table 1. Thermodynamic parameters derived from equilibrium unfolding transitions of hAR during thermal and Chemical induced unfolding studies using different probes.

Chemical
unfolding
ProbeΔG(N-I)
(KJ mol-1)
ΔG(I-U)
(KJ mol-1)
m(N-I)
(KJ mol-1 M-1)
m(I-U)
(KJ mol-1 M-1)
Cm(N-I)
(M)
Cm(I-U)
(M)
GuHCl [F314]9.47 ± 1.6958.34 ± 1.1448.34 ± 7.6923.56 ± 0.460.162.48
GuHCl-ANS [F480]16.48 ± 0.5457.26 ± 3.3338.99 ± 1.1522.38 ± 1.290.422.56
Urea [F314]30.88 ± 4.4735.04 ± 4.1613.11 ± 2.017.99 ± 0.842.354.49
Urea-ANS [F480]28.61 ± 2.3938.6 ± 2.1412.1 ± 1.138.95 ± 0.462.364.32
GuHCl [Θ219]13.68 ± 5.7834.13 ± 3.7532.17 ± 11.6314.9 ± 1.580.432.29
Urea [Θ221.8]30.53 ± 6.1624.43 ± 6.2514.12 ± 3.035.99 ± 1.302.164.08
Thermal
unfolding
ProbeΔGu
(KJ mol-1)
Tg
(K)
ΔCp
(KJ mol-1 K-1)
ΔHg
(KJ mol-1)
ΔSm
(KJ mol-1)
Tg`
(K)
Th
(K)
Ts
(K)
Temperature [Θ222]50.25329 ± 0.0117.57779.20 ± 15.362.37248284.65287.51

Chemical induced unfolding monitored by fluorescence

There are six Trp residues in hAR, out of which four are part of the hydrophobic active site pocket in the core of the β-barrel and two are buried in alpha helices surrounding the barrel. Their fluorescence provided global signal of change in tertiary structure. ANS has been extensively used as a probe for non-native, partially unfolded conformations of protein. The binding of ANS to hydrophobic regions results in a significant enhancement of ANS fluorescence and a pronounced blue-shift of the λmax16.

Fluorescence emission profiles of hAR equilibrated with different concentrations of denaturants are presented in Figure 2 (Figure 2A and Figure 3A for urea and GuHCl, respectively). A plot of λmax against denaturant concentration indicated cooperative transition from native to unfolded state (Figure 2B and Figure 3B for urea and GuHCl, respectively). In case of ANS fluorescence, significant blue-shift of around 20 nm and 10 nm from the native to intermediate state was observed for urea and GuHCl, respectively (Figure 2B2 and Figure 3B2 for urea and GuHCl, respectively).

292fcd34-6744-449e-ac7f-b211da161210_figure2.gif

Figure 2. Urea induced unfolding studies of human aldose reductase (hAR)monitored by fluorescence.

(A1) Trp fluorescence scans and (A2) ANS fluorescence scans for all the samples. (B1) λmax (Trp fluorescene) and (B2) λmax (ANS fluorescence) against [urea]. (C1) Imax (Trp fluorescenc) and (C2) Imax (ANS fluorescence) against [urea]. (D1) I295/314 (Trp fluorescence) and (D2) I370/480 (ANS fluorescence) against [urea]. (E1) Trp fluorescence and (E2) ANS fluorescence of samples in native (green), intermediate (cyan) and unfolded state (red). Solid lines represent fit to the unfolding transitions, filled symbols represent data points from unfolding experiments, red symbols represent outliers.

Plot of Imax against denaturant concentration indicated presence of an intermediate during unfolding transition (Figure 2C and Figure 3C for urea and GuHCl, respectively). Imax in case of ANS fluorescence fits satisfactorily on the basis of three-state model (Figure 2C2 and Figure 3C2 for urea and GuHCl, respectively). For both urea and GuHCl induced unfolding, Trp fluorescence emission intensity at 314 nm fits satisfactorily to three-state model. In case of ANS fluorescence, both Imax and fluorescence emission intensity at 480 nm fit equally well on the basis of three-state model. Thus, Trp fluorescence emission intensity at 314 nm and ANS fluorescence emission intensity at 480 nm were analyzed on the basis of three-state model to evaluate thermodynamic stability of hAR (Figure 2D and Figure 3D for urea and GuHCl, respectively). The thermodynamic parameters obtained from fitting are listed in Table 1. Trp and ANS fluorescence clearly demonstrate presence of an intermediate state populated at 3.5-4.0 M and 0.7-2 M urea and GuHCl concentration respectively, apart from the native and unfolded states (Figure 2E and Figure 3E for urea and GuHCl, respectively).

292fcd34-6744-449e-ac7f-b211da161210_figure3.gif

Figure 3. GuHCl-induced unfolding studies of human aldose reductase (hAR)monitored by fluorescence.

(A1) Trp fluorescence scans and (A2) ANS fluorescence scans. (B1) λmax (Trp fluorescence) and (B2) λmax (ANS fluorescence) against [GuHCl]. (C1) Imax (Trp fluorescence) and (C2) Imax (ANS fluorescence) against [GuHCl]. (D1) I295/314 (Trp fluorescence) and (D2) I370/480 (ANS fluorescence) against [GuHCl]. (E1) Trp fluorescence and (E2) ANS fluorescence of samples in native (green), intermediate (cyan) and unfolded state (red). Solid lines represent fit to the unfolding transitions, filled symbols represent data points from unfolding experiments, red symbols represent outliers.

Chemical induced unfolding monitored by far-UV CD

Unfolding profiles of hAR equilibrated at different denaturants concentrations in far-UV CD are presented in Figure 4A1 and 4A2 for GuHCl and urea, respectively. Thermodynamic stability of hAR was determined on the basis of three state model by plotting change in ellipticity at 219/222 nm as a function of denaturant concentration (Figure 4B1 and 4B2 for GuHCl and urea, respectively). The transition determined by far-UV CD detected intermediate state at similar concentrations of denaturant as interrogated by fluorescence spectroscopy. All three states can be clearly distinguished from Far-UV CD profiles (Figure 4C1 and 4C2 for GuHCl and urea, respectively). Thermodynamic parameters derived from far-UV CD data are listed in Table 1.

292fcd34-6744-449e-ac7f-b211da161210_figure4.gif

Figure 4. GuHCl/urea induced unfolding studies of human aldose reductase (hAR)monitored by far-UV circular dichroism (CD).

(A1) far-UV CD scans recorded for GuHCl and (A2) far-UV CD scans recorded for urea for all the samples. (B1) change in ellipticity at 219 nm against [GuHCl] and (B2) change in ellipticity at 221.8 nm against [urea]. (C) CD spectra of samples in native (green), intermediate (cyan) and unfolded state (red) for (C1) GuHCl and (C2) urea, respectively. Solid line represents fit to unfolding transitions, filled symbols represent data points from unfolding experiments and red symbols represent outliers in data fitting.

Discussion

The intermediate state with enhanced ANS fluorescence and significant blue shift of λmax pointed to an intermediate state with some sort of ‘molten’ nature during hAR unfolding. Far-UV CD studies strongly suggest that the intermediate state retains significant secondary structure during urea- and GuHCl-induced unfolding.

During chemical induced unfolding hAR unfolds through an intermediate state which is absent during thermal unfolding. Moderate concentration of denaturant is known to stabilize native or intermediate state17. Absence of such stabilizing agent may be the reason that the intermediate state was not detected during thermal unfolding.

In all three probes used in studying unfolding, value of ΔG(N-I) obtained is ~30 kJ mol-1 and ~15 kJ mol-1for urea- and GuHCl-induced unfolding respectively while a ∆Gs of ~70 kJ mol-1 is almost same for both denaturants (Table 1). Thus, while urea seems to stabilize the native state with respect to the intermediate state, GuHCl seems to stabilize the intermediate state with respect to the native state.

It is known that small molecules change the free energy landscape of protein upon binding by selectively stabilizing native or intermediate/unfolded state18. Difference in value of ∆Gs obtained from thermal and chemical induced unfolding is ~20 kJ mol-1 (Table 1), which is most likely due to free energy of stabilization and destabilization by urea and GuHCl, respectively.

Values of ΔG(N-I) obtained from analysis of ANS fluorescence data are 16.48 and 28.61 kJ mol-1 for GuHCl and urea, respectively (Table 1), which indicate that intermediate state is not separated by a steep energy barrier from native state. Values for ΔG(I-U) obtained from ANS fluorescence are 57.26 and 38.6 kJ mol-1 for GuHCl and urea respectively (Table 1), which indicate that the intermediate state is separated from unfolded state by a high energy barrier. Thus, the intermediate state of hAR is close to its native state which makes it functionally more relevant.

In summary, equilibrium unfolding studies of hAR have led us to discover that hAR unfolds through an intermediate state, which is close to native state, and might have physiological relevance under hyperglycemic conditions in diabetes.

Data availability

Underlying data

Figshare: data_f1000_hAR_unfolding.zip. https://doi.org/10.6084/m9.figshare.8001998.v115.

This project contains raw data for chemically and thermally induced unfolding studies on human aldose reductase.

Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 26 Apr 2019
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Sekhon G and Singh R. Human aldose reductase unfolds through an intermediate. [version 1; peer review: 3 approved with reservations]. F1000Research 2019, 8:564 (https://doi.org/10.12688/f1000research.18963.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 26 Apr 2019
Views
65
Cite
Reviewer Report 01 Aug 2019
Yong-Bin Yan, State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing, China 
Approved with Reservations
VIEWS 65
In this research, the authors studied the equilibrium unfolding pathway of human aldose reductase (hAR) by spectroscopic methods. Although this pure unfolding study may provide information of how hAR unfolds, the underlying physiological relevance is unclear. Furthermore, the present study ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Yan YB. Reviewer Report For: Human aldose reductase unfolds through an intermediate. [version 1; peer review: 3 approved with reservations]. F1000Research 2019, 8:564 (https://doi.org/10.5256/f1000research.20788.r51586)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
79
Cite
Reviewer Report 08 Jul 2019
Vladimir Uversky, Department of Molecular Medicine, College of Medicine, University of South Florida, Tampa, FL, USA 
Approved with Reservations
VIEWS 79
In this manuscript, Gurprit Sekhon and Ranvir Singh describe the results of the equilibrium unfolding of human aldose reductase. The authors conclude that urea- and GuHCL-induced unfolding of this protein is characterized by the presence of partially folded intermediate. This ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Uversky V. Reviewer Report For: Human aldose reductase unfolds through an intermediate. [version 1; peer review: 3 approved with reservations]. F1000Research 2019, 8:564 (https://doi.org/10.5256/f1000research.20788.r50821)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
88
Cite
Reviewer Report 24 Jun 2019
Jonathan W. Mueller, Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK 
Approved with Reservations
VIEWS 88
Drs Sekhon and Singh have presented an in-vitro study "Human aldose reductase unfolds through an intermediate" to F1000Research to be considered for indexing. Foremost, the authors should describe the newly described intermediate more with respect to its potential physiological relevance ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Mueller JW. Reviewer Report For: Human aldose reductase unfolds through an intermediate. [version 1; peer review: 3 approved with reservations]. F1000Research 2019, 8:564 (https://doi.org/10.5256/f1000research.20788.r50315)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 26 Apr 2019
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.